person · Reporting owner

BOUSBIB ARI

Disclosed activity across 4 companies

Tapewire entity: 10764
SEC CIK: 0001184180

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
HOME DEPOT, INC.HD · Entity 2816	Director	May 21, 2026	May 26, 2026
IQVIA HOLDINGS INC.IQV · Entity 3058	Director · See Remarks	July 29, 2026	July 31, 2026
RTX CorpUTX · Entity 2823	Pres., Commercial & UTC EVP	March 25, 2010	March 26, 2010

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

HOME DEPOT, INC.

Report date May 21, 2026 · Filed May 26, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Deferred SharesSEC Table II · derivative / convertible security	Direct	90,686.4078	Reported balance After 2026-05-21 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-05-21 · Grant · Acquired 796 · Balance 90,686.4078 F1: The Deferred Shares were granted under The Home Depot, Inc. Omnibus Stock Incentive Plan, as amended and restated May 19, 2022, and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. Vesting of shares occurs on the date of the next annual shareholders meeting.
Deferred Stock UnitsSEC Table II · derivative / convertible security	Direct	23,611.6067	Reported balance After 2026-05-21 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-05-21 · Grant · Acquired 270.8908 · Balance 23,611.6067 F2: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan.

Filing footnotes · ownership attribution and instrument terms

F1: The Deferred Shares were granted under The Home Depot, Inc. Omnibus Stock Incentive Plan, as amended and restated May 19, 2022, and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. Vesting of shares occurs on the date of the next annual shareholders meeting.

F2: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan.

IQVIA HOLDINGS INC.

Report date July 29, 2026 · Filed July 31, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	835,941	Ending reported balance After 2026-07-29 transaction · row 7 7 source rows · reconciled sequence Row 1 · 2026-07-29 · Exercise / conversion · Acquired 156,206 · Balance 992,147 F1: Represents the exercise of stock appreciation rights expiring on February 2, 2027. Row 2 · 2026-07-29 · Sale · Disposed 4,465 · Balance 987,682 F1: Represents the exercise of stock appreciation rights expiring on February 2, 2027. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.00 to $247.18, inclusive. Row 3 · 2026-07-29 · Sale · Disposed 4,584 · Balance 983,098 F1: Represents the exercise of stock appreciation rights expiring on February 2, 2027. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.70 to $247.05, inclusive. Row 4 · 2026-07-29 · Sale · Disposed 44,039 · Balance 939,059 F1: Represents the exercise of stock appreciation rights expiring on February 2, 2027. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.70 to $246.58, inclusive. Row 5 · 2026-07-29 · Sale · Disposed 53,191 · Balance 885,868 F1: Represents the exercise of stock appreciation rights expiring on February 2, 2027. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.60 to $245.60, inclusive. Row 6 · 2026-07-29 · Disposition to issuer · Disposed 47,858 · Balance 838,010 F1: Represents the exercise of stock appreciation rights expiring on February 2, 2027. Row 7 · 2026-07-29 · Disposition to issuer · Disposed 2,069 · Balance 835,941 F1: Represents the exercise of stock appreciation rights expiring on February 2, 2027.
Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $78.21 · Expires 2027-02-02	Direct	0	Reported balance After 2026-07-29 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2026-07-29 · Exercise / conversion · Disposed 156,206 · Balance 0
Common StockSEC Table I · non-derivative	IndirectBy Trust	543,302	Reported balance Holding disclosure · report date 2026-07-29 · row 8 Holding and transaction disclosures are not merged. 1 source row Row 8 · Balance 543,302 F6: Shares held in Orohena Trust.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the exercise of stock appreciation rights expiring on February 2, 2027.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.00 to $247.18, inclusive.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.70 to $247.05, inclusive.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.70 to $246.58, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.60 to $245.60, inclusive.

F6: Shares held in Orohena Trust.

RTX Corp

Report date March 25, 2010 · Filed March 26, 2010

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	69,365	Ending reported balance After 2010-03-25 transaction · row 6 6 source rows · reconciled sequence Row 1 · 2010-03-25 · Exercise / conversion · Acquired 75,000 · Balance 144,365 Row 2 · 2010-03-25 · Sale · Disposed 5,600 · Balance 138,765 Row 3 · 2010-03-25 · Sale · Disposed 9,400 · Balance 129,365 Row 4 · 2010-03-25 · Sale · Disposed 15,000 · Balance 114,365 Row 5 · 2010-03-25 · Sale · Disposed 15,000 · Balance 99,365 Row 6 · 2010-03-25 · Sale · Disposed 30,000 · Balance 69,365
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.50 · Expires 2011-04-25	Direct	75,000	Reported balance After 2010-03-25 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2010-03-25 · Exercise / conversion · Disposed 75,000 · Balance 75,000
Common StockSEC Table I · non-derivative	IndirectBy Savings Plan Trustee	7,462.849	Reported balance Holding disclosure · report date 2010-03-25 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 7,462.849
Common StockSEC Table I · non-derivative	IndirectBy Trust	30,390	Reported balance Holding disclosure · report date 2010-03-25 · row 8 Holding and transaction disclosures are not merged. 1 source row Row 8 · Balance 30,390

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

IMS Health Holdings, Inc.

Report date October 03, 2016 · Filed October 03, 2016

Section 16 reporting ended · disclosed 2016-10-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Ending reported balance After 2016-10-03 transaction · row 3 3 source rows · reconciled sequence Row 1 · 2016-10-03 · Grant · Acquired 95,704 · Balance 1,767,850 F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. F2: On February 10, 2015, the reporting person was granted 80,289 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2015 - December 31, 2017). In connection with the merger and based on the performance criteria achieved, 95,704 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 36,750 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2017. Row 2 · 2016-10-03 · Grant · Acquired 149,283 · Balance 1,917,133 F3: On February 2, 2016, the reporting person was granted 108,412 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2016 - December 31, 2018). In connection with the merger and based on the performance criteria achieved, 149,283 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 57,324 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2018. Row 3 · 2016-10-03 · Disposition to issuer · Disposed 1,917,133 · Balance 0 F4: Disposed of pursuant to merger agreement in exchange for 736,177 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
Common StockSEC Table I · non-derivative	IndirectBy Trust	Reported balance After 2016-10-03 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2016-10-03 · Disposition to issuer · Disposed 1,414,850 · Balance 0 F5: Disposed of pursuant to merger agreement in exchange for 543,302 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. F6: Shares held in Orohena Trust.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.80 · Expires 2020-12-01	Direct	Reported balance After 2016-10-03 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2016-10-03 · Disposition to issuer · Disposed 500,000 · Balance 0 F7: This option was assumed by Quintiles in the merger and replaced with an option to purchase 192,000 shares of Quintiles IMS Holdings, Inc. common stock at a price of $28.13 per share.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.20 · Expires 2020-12-01	Direct	Reported balance After 2016-10-03 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2016-10-03 · Disposition to issuer · Disposed 500,000 · Balance 0 F8: This option was assumed by Quintiles in the merger and replaced with an option to purchase 192,000 shares of Quintiles IMS Holdings, Inc. common stock at a price of $21.36 per share.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2020-12-01	Direct	Reported balance After 2016-10-03 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2016-10-03 · Disposition to issuer · Disposed 1,200,000 · Balance 0 F9: This option was assumed by Quintiles in the merger and replaced with an option to purchase 460,800 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.80 · Expires 2020-12-01	Direct	Reported balance After 2016-10-03 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2016-10-03 · Disposition to issuer · Disposed 600,000 · Balance 0 F10: This option was assumed by Quintiles in the merger and replaced with an option to purchase 230,400 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.20 · Expires 2020-12-01	Direct	Reported balance After 2016-10-03 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2016-10-03 · Disposition to issuer · Disposed 1,200,000 · Balance 0 F11: This option was assumed by Quintiles in the merger and replaced with an option to purchase 460,800 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share.
Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $25.02 · Expires 2025-02-10	Direct	Reported balance After 2016-10-03 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2016-10-03 · Disposition to issuer · Disposed 53,937 · Balance 0 F12: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 20,711 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.
Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $25.02 · Expires 2025-02-10	Direct	Reported balance After 2016-10-03 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2016-10-03 · Disposition to issuer · Disposed 161,812 · Balance 0 F14: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 62,136 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share. F13: This stock appreciation right vests in three annual installments beginning on February 10, 2017.
Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $23.00 · Expires 2026-02-02	Direct	Reported balance After 2016-10-03 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2016-10-03 · Disposition to issuer · Disposed 332,272 · Balance 0 F16: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 127,592 shares of Quintiles IMS Holdings, Inc. common stock at a price of $59.90 per share. F15: This stock appreciation right vests in four annual installments beginning on February 2, 2017.

Filing footnotes · ownership attribution and instrument terms

F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc.

F2: On February 10, 2015, the reporting person was granted 80,289 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2015 - December 31, 2017). In connection with the merger and based on the performance criteria achieved, 95,704 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 36,750 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2017.

F3: On February 2, 2016, the reporting person was granted 108,412 performance-based restricted stock units. The shares are earned based on the company's financial results over a three-year period (January 1, 2016 - December 31, 2018). In connection with the merger and based on the performance criteria achieved, 149,283 shares of issuer common stock were issued to the recipient. The performance-based restricted stock unit was assumed by Quintiles in the merger and replaced with a time-based restricted stock unit of 57,324 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. The shares will vest on December 31, 2018.

F4: Disposed of pursuant to merger agreement in exchange for 736,177 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.

F5: Disposed of pursuant to merger agreement in exchange for 543,302 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.

F6: Shares held in Orohena Trust.

F7: This option was assumed by Quintiles in the merger and replaced with an option to purchase 192,000 shares of Quintiles IMS Holdings, Inc. common stock at a price of $28.13 per share.

F8: This option was assumed by Quintiles in the merger and replaced with an option to purchase 192,000 shares of Quintiles IMS Holdings, Inc. common stock at a price of $21.36 per share.

F9: This option was assumed by Quintiles in the merger and replaced with an option to purchase 460,800 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share.

F10: This option was assumed by Quintiles in the merger and replaced with an option to purchase 230,400 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share.

F11: This option was assumed by Quintiles in the merger and replaced with an option to purchase 460,800 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share.

F12: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 20,711 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.

F13: This stock appreciation right vests in three annual installments beginning on February 10, 2017.

F14: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 62,136 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share.

F15: This stock appreciation right vests in four annual installments beginning on February 2, 2017.

F16: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 127,592 shares of Quintiles IMS Holdings, Inc. common stock at a price of $59.90 per share.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 23, 2019 Filed May 28, 2019 22:11 UTC	HOME DEPOT, INC. HD · Entity 2816	GrantDeferred Stock Units · Derivative	338.5417	$192.00	$65,000.01	Disclosure SEC source: 0001209191-19-033069 · doc4.xml · derivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,356.9432 Underlying: Common Stock · 338.5417 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan. F2 · derivative.exercise_date: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan. F2 · derivative.expiration_date: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan. Read SEC document
May 23, 2019 Filed May 28, 2019 22:11 UTC	HOME DEPOT, INC. HD · Entity 2816	GrantDeferred Shares · Derivative	1,197.9167	$0.00	$0.00	Disclosure SEC source: 0001209191-19-033069 · doc4.xml · derivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,457.8061 Underlying: Common Stock · 1,197.9167 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. F1 · derivative.exercise_date: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. F1 · derivative.expiration_date: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. Read SEC document
March 25, 2019 Filed Mar 27, 2019 21:02 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherEmployee Stock Option (Right to Buy) · Derivative	96,000	$0.00 Strike: $21.36	$0.00	Disclosure SEC source: 0001478242-19-000023 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,000 shares Expires 2020-12-01 Read SEC document
March 25, 2019 Filed Mar 27, 2019 21:02 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	96,000	$140.96	$13,532,160.00	Disclosure SEC source: 0001478242-19-000023 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 730,137 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $139.99 to $141.59 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
March 25, 2019 Filed Mar 27, 2019 21:02 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	96,000	$21.36	$2,050,560.00	Disclosure SEC source: 0001478242-19-000023 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 826,137 Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:29 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherEmployee Stock Option (Right to Buy) · Derivative	96,000	$0.00 Strike: $21.36	$0.00	Disclosure SEC source: 0001478242-19-000015 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,000 Underlying: Common Stock · 96,000 shares Expires 2020-12-01 Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:29 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	96,000	$140.00	$13,440,000.00	Disclosure SEC source: 0001478242-19-000015 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 730,137 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018. Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:29 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	96,000	$21.36	$2,050,560.00	Disclosure SEC source: 0001478242-19-000015 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 826,137 Read SEC document
February 13, 2019 Filed Feb 15, 2019 22:12 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantStock Appreciation Right · Derivative	184,364	$0.00 Strike: $131.82	$0.00	Disclosure SEC source: 0001478242-19-000012 · edgar.xml · derivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,364 Underlying: Common Stock · 184,364 shares Expires 2029-02-13 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/13/2020. Read SEC document
February 02, 2019 Filed Feb 5, 2019 22:03 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	30,009	$129.56	$3,887,966.04	Disclosure SEC source: 0001478242-19-000005 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 730,137 Read SEC document
December 31, 2018 Filed Jan 3, 2019 22:15 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	28,071	$116.17	$3,261,008.07	Disclosure SEC source: 0001478242-19-000001 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 760,146 Read SEC document
July 26, 2018 Filed Jul 31, 2018 00:13 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherEmployee Stock Option (Right to Buy) · Derivative	368,640	$0.00 Strike: $26.05	$0.00	Disclosure SEC source: 0001478242-18-000049 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 368,640 shares Expires 2020-12-01 Read SEC document
July 26, 2018 Filed Jul 31, 2018 00:13 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	368,640	$122.09	$45,007,257.60	Disclosure SEC source: 0001478242-18-000049 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 788,217 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2018 F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $120.94 to $124.60 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
July 26, 2018 Filed Jul 31, 2018 00:13 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherCommon Stock	368,640	$26.05	$9,603,072.00	Disclosure SEC source: 0001478242-18-000049 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,156,857 Read SEC document
June 15, 2018 Filed Jun 19, 2018 21:35 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherEmployee Stock Option (Right to Buy) · Derivative	92,160	$0.00 Strike: $26.05	$0.00	Disclosure SEC source: 0001478242-18-000040 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,640 Underlying: Common Stock · 92,160 shares Expires 2020-12-01 Read SEC document
June 15, 2018 Filed Jun 19, 2018 21:35 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	92,160	$103.20	$9,510,912.00	Disclosure SEC source: 0001478242-18-000040 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 788,217 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $103.05 to $103.40 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
June 15, 2018 Filed Jun 19, 2018 21:35 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherCommon Stock	92,160	$26.05	$2,400,768.00	Disclosure SEC source: 0001478242-18-000040 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 880,377 Read SEC document
May 17, 2018 Filed May 21, 2018 22:48 UTC	HOME DEPOT, INC. HD · Entity 2816	GrantDeferred Stock Units · Derivative	350.7257	$185.33	$64,999.99	Disclosure SEC source: 0001209191-18-032105 · doc4.xml · derivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,607.1674 Underlying: Common Stock · 350.7257 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan. F2 · derivative.exercise_date: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan. F2 · derivative.expiration_date: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan. Read SEC document
May 17, 2018 Filed May 21, 2018 22:48 UTC	HOME DEPOT, INC. HD · Entity 2816	GrantDeferred Shares · Derivative	1,241.0295	$0.00	$0.00	Disclosure SEC source: 0001209191-18-032105 · doc4.xml · derivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,656.3474 Underlying: Common Stock · 1,241.0295 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. F1 · derivative.exercise_date: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. F1 · derivative.expiration_date: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. Read SEC document
February 12, 2018 Filed Feb 14, 2018 23:43 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	92,106	$98.63	$9,084,414.78	Disclosure SEC source: 0001478242-18-000010 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 788,217 Read SEC document
February 08, 2018 Filed Feb 13, 2018 02:55 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantStock Appreciation Right · Derivative	160,457	$0.00 Strike: $95.23	$0.00	Disclosure SEC source: 0001478242-18-000009 · edgar.xml · derivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,457 Underlying: Common Stock · 160,457 shares Expires 2028-02-08 F1 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/08/2019. Read SEC document
December 31, 2017 Filed Jan 3, 2018 21:39 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	Tax withholdingCommon Stock	110,436	$97.90	$10,811,684.40	Disclosure SEC source: 0001478242-18-000002 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 880,323 Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:13 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherEmployee Stock Option (Right to Buy) · Derivative	46,080	$0.00 Strike: $15.11	$0.00	Disclosure SEC source: 0001478242-17-000077 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,240 Underlying: Common Stock · 46,080 shares Expires 2020-12-01 Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:13 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	46,080	$101.79	$4,690,483.20	Disclosure SEC source: 0001478242-17-000077 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,759 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2017. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $100.56 to $102.72 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:13 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherCommon Stock	46,080	$15.11	$696,268.80	Disclosure SEC source: 0001478242-17-000077 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036,839 Read SEC document
November 01, 2017 Filed Nov 3, 2017 20:14 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	OtherEmployee Stock Option (Right to Buy) · Derivative	46,080	$0.00 Strike: $15.11	$0.00	Disclosure SEC source: 0001478242-17-000068 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,320 Underlying: Common Stock · 46,080 shares Expires 2020-12-01 Read SEC document
November 01, 2017 Filed Nov 3, 2017 20:14 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	SaleCommon Stock	46,080	$108.14	$4,983,091.20	Disclosure SEC source: 0001478242-17-000068 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,759 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2017. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $107.60 to $108.78 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
November 01, 2017 Filed Nov 3, 2017 20:14 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	OtherCommon Stock	46,080	$15.11	$696,268.80	Disclosure SEC source: 0001478242-17-000068 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036,839 Read SEC document
October 02, 2017 Filed Oct 3, 2017 20:23 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	OtherEmployee Stock Option (Right to Buy) · Derivative	46,080	$0.00 Strike: $8.34	$0.00	Disclosure SEC source: 0001478242-17-000063 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,480 Underlying: Common Stock · 46,080 shares Expires 2020-12-01 Read SEC document
October 02, 2017 Filed Oct 3, 2017 20:23 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	SaleCommon Stock	46,080	$94.91	$4,373,452.80	Disclosure SEC source: 0001478242-17-000063 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,759 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2017. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $94.48 to $95.29 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
October 02, 2017 Filed Oct 3, 2017 20:23 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	OtherCommon Stock	46,080	$8.34	$384,307.20	Disclosure SEC source: 0001478242-17-000063 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036,839 Read SEC document
September 01, 2017 Filed Sep 6, 2017 20:27 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	OtherEmployee Stock Option (Right to Buy) · Derivative	46,080	$0.00 Strike: $8.34	$0.00	Disclosure SEC source: 0001478242-17-000058 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,560 Underlying: Common Stock · 46,080 shares Expires 2020-12-01 Read SEC document
September 01, 2017 Filed Sep 6, 2017 20:27 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	SaleCommon Stock	46,080	$95.65	$4,407,552.00	Disclosure SEC source: 0001478242-17-000058 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,759 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2017. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $95.29 to $96.37 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
September 01, 2017 Filed Sep 6, 2017 20:27 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	OtherCommon Stock	46,080	$8.34	$384,307.20	Disclosure SEC source: 0001478242-17-000058 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036,839 Read SEC document
August 07, 2017 Filed Aug 7, 2017 23:15 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	OtherEmployee Stock Option (Right to Buy) · Derivative	92,160	$0.00 Strike: $8.34	$0.00	Disclosure SEC source: 0001478242-17-000050 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,640 Underlying: Common Stock · 92,160 shares Expires 2020-12-01 Read SEC document
August 07, 2017 Filed Aug 7, 2017 23:15 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	SaleCommon Stock	92,160	$90.35	$8,326,656.00	Disclosure SEC source: 0001478242-17-000050 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,759 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2017. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $89.97 to $90.93 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
August 07, 2017 Filed Aug 7, 2017 23:15 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	OtherCommon Stock	92,160	$8.34	$768,614.40	Disclosure SEC source: 0001478242-17-000050 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,082,919 Read SEC document
May 18, 2017 Filed May 22, 2017 22:03 UTC	HOME DEPOT, INC. HD · Entity 2816	GrantDeferred Stock Units · Derivative	417.4695	$155.70	$65,000.00	Disclosure SEC source: 0001209191-17-034416 · doc4.xml · derivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,881.5675 Underlying: Common Stock · 417.4695 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan. F2 · derivative.exercise_date: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan. F2 · derivative.expiration_date: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan. Read SEC document
May 18, 2017 Filed May 22, 2017 22:03 UTC	HOME DEPOT, INC. HD · Entity 2816	GrantDeferred Shares · Derivative	1,477.1997	$0.00	$0.00	Disclosure SEC source: 0001209191-17-034416 · doc4.xml · derivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,950.8062 Underlying: Common Stock · 1,477.1997 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. F1 · derivative.exercise_date: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. F1 · derivative.expiration_date: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. Read SEC document
February 02, 2017 Filed Feb 6, 2017 22:08 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	GrantStock Appreciation Right · Derivative	156,206	$0.00 Strike: $78.21	$0.00	Disclosure SEC source: 0001478242-17-000005 · edgar.xml · derivative · entry 3 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,206 Underlying: Common Stock · 156,206 shares Expires 2027-02-02 F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on 02/02/2018. Read SEC document
February 02, 2017 Filed Feb 6, 2017 22:08 UTC	IQVIA HOLDINGS INC. Q · Entity 3058	GrantCommon Stock	254,582	$0.00	$0.00	Disclosure SEC source: 0001478242-17-000005 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,759 F1 · shares: Represents a grant of restricted stock received as an award under the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan, for no consideration, and exempt pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended. The restricted stock will vests 25% on February 2, 2019, 25% on February 2, 2020 and 50% on February 2, 2021. Read SEC document
October 03, 2016 Filed Oct 3, 2016 22:56 UTC	IMS Health Holdings, Inc. IMS · Entity 174539	Disposition to issuerStock Appreciation Right · Derivative	332,272	Not disclosed Strike: $23.00	Not disclosed	Disclosure SEC source: 0001595262-16-000066 · edgar.xml · derivative · entry 12 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 332,272 shares Expires 2026-02-02 F16 · price: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 127,592 shares of Quintiles IMS Holdings, Inc. common stock at a price of $59.90 per share. F15 · derivative.exercise_date: This stock appreciation right vests in four annual installments beginning on February 2, 2017. Read SEC document
October 03, 2016 Filed Oct 3, 2016 22:56 UTC	IMS Health Holdings, Inc. IMS · Entity 174539	Disposition to issuerStock Appreciation Right · Derivative	161,812	Not disclosed Strike: $25.02	Not disclosed	Disclosure SEC source: 0001595262-16-000066 · edgar.xml · derivative · entry 11 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 161,812 shares Expires 2025-02-10 F14 · price: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 62,136 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share. F13 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 10, 2017. Read SEC document
October 03, 2016 Filed Oct 3, 2016 22:56 UTC	IMS Health Holdings, Inc. IMS · Entity 174539	Disposition to issuerStock Appreciation Right · Derivative	53,937	Not disclosed Strike: $25.02	Not disclosed	Disclosure SEC source: 0001595262-16-000066 · edgar.xml · derivative · entry 10 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,937 shares Expires 2025-02-10 F12 · price: This stock appreciation right was assumed by Quintiles in the merger and replaced with a stock appreciation right to purchase 20,711 shares of Quintiles IMS Holdings, Inc. common stock at a price of $65.16 per share. Read SEC document
October 03, 2016 Filed Oct 3, 2016 22:56 UTC	IMS Health Holdings, Inc. IMS · Entity 174539	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	1,200,000	Not disclosed Strike: $3.20	Not disclosed	Disclosure SEC source: 0001595262-16-000066 · edgar.xml · derivative · entry 9 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200,000 shares Expires 2020-12-01 F11 · price: This option was assumed by Quintiles in the merger and replaced with an option to purchase 460,800 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share. Read SEC document
October 03, 2016 Filed Oct 3, 2016 22:56 UTC	IMS Health Holdings, Inc. IMS · Entity 174539	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	600,000	Not disclosed Strike: $5.80	Not disclosed	Disclosure SEC source: 0001595262-16-000066 · edgar.xml · derivative · entry 8 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 600,000 shares Expires 2020-12-01 F10 · price: This option was assumed by Quintiles in the merger and replaced with an option to purchase 230,400 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share. Read SEC document
October 03, 2016 Filed Oct 3, 2016 22:56 UTC	IMS Health Holdings, Inc. IMS · Entity 174539	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	1,200,000	Not disclosed Strike: $10.00	Not disclosed	Disclosure SEC source: 0001595262-16-000066 · edgar.xml · derivative · entry 7 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200,000 shares Expires 2020-12-01 F9 · price: This option was assumed by Quintiles in the merger and replaced with an option to purchase 460,800 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share. Read SEC document
October 03, 2016 Filed Oct 3, 2016 22:56 UTC	IMS Health Holdings, Inc. IMS · Entity 174539	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	500,000	Not disclosed Strike: $8.20	Not disclosed	Disclosure SEC source: 0001595262-16-000066 · edgar.xml · derivative · entry 6 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires 2020-12-01 F8 · price: This option was assumed by Quintiles in the merger and replaced with an option to purchase 192,000 shares of Quintiles IMS Holdings, Inc. common stock at a price of $21.36 per share. Read SEC document
October 03, 2016 Filed Oct 3, 2016 22:56 UTC	IMS Health Holdings, Inc. IMS · Entity 174539	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	500,000	Not disclosed Strike: $10.80	Not disclosed	Disclosure SEC source: 0001595262-16-000066 · edgar.xml · derivative · entry 5 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires 2020-12-01 F7 · price: This option was assumed by Quintiles in the merger and replaced with an option to purchase 192,000 shares of Quintiles IMS Holdings, Inc. common stock at a price of $28.13 per share. Read SEC document
October 03, 2016 Filed Oct 3, 2016 22:56 UTC	IMS Health Holdings, Inc. IMS · Entity 174539	Disposition to issuerCommon Stock	1,414,850	Not disclosed	Not disclosed	Disclosure SEC source: 0001595262-16-000066 · edgar.xml · nonDerivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 F5 · price: Disposed of pursuant to merger agreement in exchange for 543,302 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. F6 · ownership.nature: Shares held in Orohena Trust. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.